Promising results of VCE-004 new analogs on the treatment of diet-induced obesity

11/05/2015

Córdoba, May 11st 2015. Vivacell is pleased to announce that several VCE-004 derivatives have shown promising results in the treatment of murine models of obesity. In collaboration with the internationally recognized researchers Prof. Tena-Sempere and Prof. Muñoz-Blanco of Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Vivacell presented the results in the III Meeting of Young Researches organized by Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC) last week. This new R&D line enhances the pipeline of VivaCell and increases the potential range of therapeutic uses of the new quinone derivatives of VCE-004, which has been recently protected by international patent.

Developed with DoPlanning